In a recent article posted to the medRxiv* preprint server, scientists explored the coronavirus disease 2019 (COVID-19) BNT162b2 vaccine triggered non-neutralizing and neutralizing antibody functions.

Neutralizing antibody titers have been found to be strongly correlated with observed vaccine effectiveness against symptomatic and severe COVID-19. Few non-high complexity assays are currently ...

Researchers have been able to directly visualize the neutral products of the mutual neutralization of hydronium and hydroxide, and report three different product channels: two channels were attributed ...

When human immunodeficiency virus (HIV) emerged and was identified as the cause of acquired immunodeficiency syndrome (AIDS), it was expected that a vaccine would be developed eventually. By over ...

The changing landscape of SARS-CoV-2 Spike protein is linked to the emergence of variants, immune-escape and reduced efficacy of the existing repertoire of anti-viral antibodies. The functional ...

Serum samples obtained from unvaccinated persons after infection with the B.1.1.7 (alpha), B.1.351 (beta), or B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...

Therefore, we administered a third 30-μg BNT162b2 dose 7.9 to 8.8 months after dose 2 to 11 participants 18 to 55 years of age and to 12 participants 65 to 85 years of age from U.S. sites in the phase ...

In a recent study posted to the bioRxiv* preprint server, scientists analyzed the antigenic characteristics of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.5 and BA.4 ...